Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS: We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS: The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS: Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence shows risk at lower doses (<0.5 Gy), with an estimated latency of 10 years or more29–31.”
From Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars (2020) · cites this paper as [29]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
(2011) · The Lancet · doi:10.1016/s0140-6736(11)61629-2 · Cited by 3,937
Self-citationCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
The completeness of the Swedish Cancer Register – a sample survey for year 1998
Barlow, L., Westergren, K., Holmberg, L., & Talbäck, M. (2009) · Acta Oncologica · doi:10.1080/02841860802247664 · Cited by 1,236
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationDarby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Self-citationLifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Jones B, 2001, Clin Oncol (R Coll Radiol), 13, 71
Cited by
Items 801–900 of 1,001
Walston, S., Quick, A. M., Kuhn, K., & Rong, Y. (2016) · Technology in Cancer Research & Treatment · doi:10.1177/1533034615624311 · Cited by 34
“Therefore, these risk assessments are established from outdated techniques and are not necessarily applicable to current practice.(5,7,8,10,27,28) Not only are these older techniques obsolete, but in most cases, the doses delivered to normal tissues are retrospectively estimated without the ability to evaluate 3D CT s…”
InfluentialConroy, L., Yeung, R. H., Watt, E., Quirk, S., Long, K., Hudson, A., Phan, T., & Smith, W. L. (2016) · Journal of Applied Clinical Medical Physics · doi:10.1120/jacmp.v17i4.6188 · Cited by 32
“(1,2) However, WBRT has also been shown to increase the risk of long-term cardiac disease,(3) particularly in left-sided breast cancer patients.”
BackgroundMajor, T., Stelczer, G., Pesznyák, C., Mészáros, N., & Polgár, C. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.08.003 · Cited by 32
“[45] the risk of major cardiac events increases linearly by 7.”
BackgroundKura, B., YIN, C., Frimmel, K., Krizak, J., Okruhlicová, Ľ., Kukreja, R. C., & Slezák, J. (2016) · Physiological Research · doi:10.33549/physiolres.933399 · Cited by 32
“In fact, epidemiological evidence has established a clear link between cardiovascular disease and exposure of the heart and major vessels to radiation doses (e.g. radiation therapy) (Darby et al. 2013).”
BackgroundTanna, N., McLauchlan, R., Karis, S., Welgemoed, C., Gujral, D. M., & Cleator, S. J. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.01.004 · Cited by 32
Coutinho, A. D., Makenbaeva, D., Farrelly, E., Landsman-Blumberg, P. B., & Lenihan, D. J. (2017) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2017.06.011 · Cited by 32
van Rosendael, A. R., Daniels, L. A., Dimitriu‐Leen, A. C., Smit, J. M., van Rosendael, P. J., Schalij, M. J., Bax, J. J., & Scholte, A. J. H. A. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.09.008 · Cited by 32
Haefner, M. F., Verma, V., Bougatf, N., Mielke, T., Tonndorf‐Martini, E., König, L., Rwigema, J. M., Simone, C. B., Uhlmann, L., Eichhorn, F., et al. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1502467 · Cited by 32
“The negative effect of even low-dose exposure to the heart on cardiac morbidity has been clearly demonstrated [4,39].”
BackgroundmiR-29b Mediates the Chronic Inflammatory Response in Radiotherapy-Induced Vascular Disease
Eken, S. M., Christersdottir, T., Winski, G., Sangsuwan, T., Jin, H. H., Chernogubova, E., Pirault, J., Sun, C., Simon, N. L., Winter, H., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.10.006 · Cited by 32
“In a manner proportional to radiation dosage and location, radiation therapy for breast cancer and Hodgkin lymphoma increases the risk for ischemic heart disease (6,7).”
BackgroundThe circadian clock protects against ionizing radiation‐induced cardiotoxicity
Dakup, P., Porter, K. I., Gajula, R. P., Goel, P. N., Cheng, Z., & Gaddameedhi, S. (2020) · The FASEB Journal · doi:10.1096/fj.201901850rr · Cited by 33
Sun, F., Franks, K., Murray, L. J., Lilley, J., Wheller, B., Banfill, K., McWilliam, A., Abravan, A., van Herk, M., Finn, C. F., et al. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.05.004 · Cited by 35
Loap, P., Tkatchenko, N., & Kirova, Y. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2020.04.012 · Cited by 32
Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors
Aizer, A. A., Du, R., Wen, P. Y., & Arvold, N. D. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1839-5 · Cited by 33
Breast cancer and cardiovascular health
López‐Fernández, T., Clement, I. M., Aznar, M. C., Barac, A., Bergler-Klein, J. K., Meattini, I., Scott, J. M., Cardinale, D. M., & Dent, S. F. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae637 · Cited by 35
D’Errico, M. P., Petruzzelli, M. F., Gianicolo, E., Grimaldi, L., Loliva, F., Tramacere, F., Andreassi, M. G., Pili, G., Picano, E., & Portaluri, M. G. A. (2015) · International Journal of Radiation Biology · doi:10.3109/09553002.2015.1027421 · Cited by 31
“); very recently, the observation of ischemic effects within a few years from the end of RT (Darby et al. 2013) further emphasizes the need to search for biomarkers that could allow clinicians to recognize patients at risk of cardiomyopathy.”
BackgroundScott, J. M., Adams, S. C., Koelwyn, G. J., & Jones, L. W. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.03.014 · Cited by 32
Gkantaifi, A., Papadopoulos, C. E., Spyropoulou, D., Toumpourleka, M., Iliadis, G., Kardamakis, D. M., Nikolaou, M., Tsoukalas, N., Kyrgias, G., & Tolia, M. (2019) · Anticancer Research · doi:10.21873/anticanres.13272 · Cited by 31
International Variation in Criteria for Internal Mammary Chain Radiotherapy
Duane, F. K., McGale, P., Teoh, S., Mortimer, C., Broggio, J., Darby, S. C., Dodwell, D. J., Lavery, B. A., Oliveros, S., Vallis, K. A., et al. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.04.007 · Cited by 31
Self-citationCho, Y., Cho, Y. J., Chang, W. S., Kim, J. W., Choi, W. H., & Lee, I. J. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1257-5 · Cited by 31
Cardiotoxicity of radiation therapy in esophageal cancer
Vošmik, M., Hodek, M., Buka, D., Sýkorová, P., Grepl, J., Paluska, P., Paulíková, S., & Sirák, I. (2020) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2020.02.005 · Cited by 31
Finnegan, R., Lorenzen, E. L., Dowling, J., Jensen, I., Berg, M., Thomsen, M. S., Delaney, G. P., Koh, E.-S., Thwaites, D., Brink, C., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.09.004 · Cited by 31
Intrafraction motion during partial breast irradiation depends on treatment time
Hoekstra, N., Habraken, S., Swaak‐Kragten, A. T., Hoogeman, M. S., & Pignol, J. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.03.029 · Cited by 31
Kaidar‐Person, O., Fortpied, C., Hol, S., Weltens, C. G., Kirkove, C., Budach, V., Peignaux-Casasnovas, K., van der Leij, F., Vonk, E. J. A., Valli, M., et al. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.05.006 · Cited by 31
“Common practice for RT planning at that time followed bony landmarks and the use of individualised RT-techniques and imagingbased treatment planning were not practiced in most centres.”
MethodResultInfluentialDraguet, C., Montero, A. M. B., Vera, M. C., Thomas, M. L., Populaire, P., Defraene, G., Haustermans, K. M., Lee, J. A., & Sterpin, E. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.08.031 · Cited by 31
Guan, T., Jiang, Y., Luo, Z., Liang, Y., Feng, M., Lu, Z., Yi, M., Teng, Y., Zhou, R., Zeng, L., et al. (2023) · Age and Ageing · doi:10.1093/ageing/afad068 · Cited by 31
Hamada, N. (2023) · Radiation Research · doi:10.1667/rade-23-00030.1 · Cited by 32
“For IHD, heart dose predicted radiation risk better than the dose to the left anterior descending coronary artery (131).”
BackgroundMittauer, K. E., Deraniyagala, R. L., Li, J. G., Lü, B., Liu, C., Samant, S. S., Lightsey, J. L., & Yan, G. (2014) · Medical Physics · doi:10.1118/1.4903511 · Cited by 31
Incidental dose to coronary arteries is higher in prone than in supine whole breast irradiation
Würschmidt, F., Stoltenberg, S., Kretschmer, M., & Petersen, C. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-014-0606-4 · Cited by 31
Parijs, H. V., Reynders, T., Heuninckx, K., Verellen, D., Storme, G. A., & Ridder, M. D. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-36 · Cited by 32
“Considering that part of the left ventricle already has received 50 Gy with the wide tangential fields, it would probably be better to minimize the volume of heart receiving extra dose by the boost delivery [20,24].”
BackgroundWiant, D., Wentworth, S., Liu, H., & Sintay, B. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.010 · Cited by 31
Helical tomotherapy for bilateral breast cancer: Clinical experience
Kaidar‐Person, O., Kostich, M., Zagar, T. M., Jones, E., Gupta, G. P., Mavroidis, P., Das, S. K., & Marks, L. B. (2016) · The Breast · doi:10.1016/j.breast.2016.05.004 · Cited by 31
Kaidar‐Person, O., Zagar, T. M., Oldan, J. D., Matney, J. E., Jones, E. L., Das, S. K., Jensen, B. C., Zellars, R. C., Wong, T. Z., & Marks, L. B. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4248-y · Cited by 31
“[22] where RT-associated cardiac injury was noted relatively soon post-RT, contrary to the prevailing misconception that RT-induced heart injury requires years to develop.”
BackgroundRadiation-related heart disease after breast cancer radiation therapy in Korean women
Korean Breast Cancer Society, Chang, J. S., Ko, B. K., Bae, J. W., Yu, J., Park, M. H., Jung, Y. S., Jeon, Y. W., Kim, K. H., Shin, J., et al. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4398-y · Cited by 31
“5 Gy for leftand right-sided breast RT, respectively, in our study was similar to that of previous studies [1, 22].”
ResultChatterjee, S., Chakraborty, S., Arunsingh, M. A., Nallathambi, C., Mahata, A., Mandal, S., Achari, R. B., Mallick, I., Shrimali, R. K., Bhattacharyya, T., et al. (2018) · Practical Radiation Oncology · doi:10.1016/j.prro.2018.03.007 · Cited by 31
Kuo, L., Ballangrud, Å., Ho, A. Y., Mechalakos, J., Li, G., & Hong, L. X. (2018) · Medical dosimetry · doi:10.1016/j.meddos.2018.04.006 · Cited by 31
Chowdhary, M., Lee, A., Gao, S. J., Wang, D., Barry, P. N., Diaz, R., Bagadiya, N. R., Park, H. S.-M., Yu, J. B., Wilson, L. D., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00678 · Cited by 31
“4% increase in major coronary events with every 1Gy increase in mean heart dose (2).”
BackgroundInfluentialLoap, P., & Kirova, Y. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2020.05.016 · Cited by 32
Cardiovascular sequelae of radiation therapy
Santoro, F., Tarantino, N. M., Pellegrino, P. L., Caivano, M., Lopizzo, A., Biase, M. D., & Brunetti, N. D. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0718-y · Cited by 30
“Absence of irradiation shields and protective techniques [7]”
BackgroundInfluentialTrends in Cardiac Mortality in Patients With Locally Advanced Non-Small Cell Lung Cancer
Haque, W. M., Verma, V., Fakhreddine, M., Butler, E. B., Teh, B. S., & Simone, C. B. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.10.031 · Cited by 30
Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds
Newman, A. A. C., Baylis, R. A., Hess, D. L., Griffith, S. D., Shankman, L. S., Cherepanova, O. A., & Owens, G. K. (2018) · JCI Insight · doi:10.1172/jci.insight.121017 · Cited by 31
Liu, Y., Chang, H.-M., Lin, H., Lu, C.-C., & Lai, L.-H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123884 · Cited by 30
“Pericarditis may develop as the heart is irradiated, but it rarely progresses in a short duration [38].”
BackgroundLoap, P., Beddok, A., Cao, K. I., Goudjil, F., Fourquet, A., Dendale, R., & Kirova, Y. (2021) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2021.01.005 · Cited by 30
Zeleznik, R., Weiß, J., Taron, J., Guthier, C. V., Bitterman, D. S., Hancox, C., Kann, B. H., Kim, D. W., Punglia, R. S., Bredfeldt, J. S., et al. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00416-5 · Cited by 35
Effects of radiation on endothelial barrier and vascular integrity
Bouten, R. M., Young, E. F., Selwyn, R. G., Iacono, D., Rittase, W. B., & Day, R. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818561-2.00007-2 · Cited by 40
Xu, T., Meng, Q. H., Gilchrist, S. C., Lin, S. H., Lin, R., Xu, T., Milgrom, S. A., Gandhi, S. J., Wu, H., Zhao, Y., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.07.035 · Cited by 33
van Velzen, S. G. M., Gal, R., Teske, A. J., van der Leij, F., van den Bongard, H. J. G. D., Viergever, M. A., Verkooijen, H. M., & Išgum, I. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.09.008 · Cited by 30
Abraham, A., Sanghera, K. P., Gheisari, F., Koumna, S., Riauka, T., Ghosh, S., Warkentin, H., Gabos, Z., Chafe, S., Tankel, K., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.01.020 · Cited by 30
Racka, I., Majewska, K., & Winiecki, J. (2022) · Strahlentherapie und Onkologie · doi:10.1007/s00066-022-01979-2 · Cited by 33
“4% per every Gy of the mean heart dose with no apparent threshold [41].”
BackgroundWolf, J., Stoller, S., Lübke, J., Rothe, T., Serpa, M., Scholber, J., Zamboglou, C., Gkika, E., Baltas, D., Juhasz‐Böss, I., et al. (2022) · Strahlentherapie und Onkologie · doi:10.1007/s00066-022-01998-z · Cited by 30
“This dose-dependent rise occurs after a few years and persists for at least two decades [2].”
BackgroundLoap, P., Vu-Bezin, J., Monceau, V., Jacob, S., Fourquet, A., & Kirova, Y. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2177976 · Cited by 30
“While small dosimetric benefits could be overcome by time-consuming procedures and by a waste of resources, there is no identified threshold for cardiac toxicity related to MHD [29]: since the cardiotoxicity risk increases linearly with MHD [29], even small dosimetric differences may translate into disparate clinical…”
BackgroundHolt, F., Probert, J., Darby, S. C., Haviland, J., Coles, C. E., Kirby, A. M., Liu, Z., Dodwell, D. J., Ntentas, G., Duane, F. K., et al. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.02.023 · Cited by 31
Self-citationKillander, F., Anderson, H., Kjellén, E., & Malmström, P. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.04.033 · Cited by 30
“published a paper on risk of ischaemic heart disease in women after radiotherapy [34].”
BackgroundCurrent modalities of accelerated partial breast irradiation
Cox, J. A., & Swanson, T. A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.65 · Cited by 32
Cao, L., Hu, W., Kirova, Y., Yang, Z., Cai, G., Yu, X., Ma, J. L., Guo, X., Shao, Z., & Chen, J. (2014) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2014.01.001 · Cited by 30
Low dose radiation and circulatory diseases: a brief narrative review
Little, M. P., & Lipshultz, S. E. (2015) · Cardio-Oncology · doi:10.1186/s40959-015-0007-6 · Cited by 30
“The International Agency for Research on Cancer 15- country study of radiation workers found increasing dose-related trends for mortality from all circulatory disease, cerebrovascular disease, and other circulatory diseases and decreasing trends for ischemic heart disease (IHD), heart failure, deep vein thrombosis, an…”
BackgroundInfluentialBreast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology
Xie, Y., Collins, W. J., Audeh, M. W., Shiao, S. L., Gottlieb, R. A., Goodman, M. T., Merz, C. N. B., & Mehta, P. K. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0421-y · Cited by 34
Cao, L., Cai, G., Chang, C., Yang, Z.-Z., Feng, Y., Yu, X.-L., Ma, J.-L., Wu, J., Guo, X.-M., & Chen, J. (2015) · Oncotarget · doi:10.18632/oncotarget.6053 · Cited by 33
“[30] reported that increase of cardiac events was proportional to mean heart dose.”
BackgroundBrown, S., Nhola, L. F., & Herrmann, J. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.552 · Cited by 30
“ease are potent determinants of ischemic events after chest radiotherapy in individuals with breast cancer.(67) These observations as”
BackgroundLiao, N., Zhong, J., Zhang, R., Ye, X., Zhang, Y., Wang, W., Wang, Y., Chen, S., Liu, D., & Liu, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167889 · Cited by 30
Grellier, N., Chevrier, M., Fourquet, A., Costa, É., Xu, H., Berger, F., Campana, F., Laki, F., Beuzeboc, P., Lefeuvre, D., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.01.205 · Cited by 30
Sritharan, H. P., Delaney, G. P., Lo, Q., Batumalai, V., Xuan, W., & Thomas, L. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.007 · Cited by 30
Munshi, A., Sarkar, B., Anbazhagan, S., Giri, U. K., Kaur, H., Jassal, K., Ganesh, T., & Mohanti, B. K. (2017) · Australasian Physical & Engineering Sciences in Medicine · doi:10.1007/s13246-017-0558-y · Cited by 30
“Simultaneously, there is emerging data of some detriment by radiation to critical OARs such as the heart and contralateral breast [8].”
Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery
Reimer, T., Engel, J., Schmidt, M., Offersen, B. V., Smidt, M. L., & Gentilini, O. (2018) · Breast Care · doi:10.1159/000491703 · Cited by 31
Lee, C., Zhang, J.-F., Yuan, K. S., Wu, A. T. H., & Wu, S. (2019) · Strahlentherapie und Onkologie · doi:10.1007/s00066-019-01428-7 · Cited by 33
Ferris, M. J., Martin, K. S., Switchenko, J. M., Kayode, O., Wolf, J., Dang, Q. H., Press, R. H., Curran, W. J., & Higgins, K. A. (2019) · Practical Radiation Oncology · doi:10.1016/j.prro.2019.04.013 · Cited by 31
Esplugas, R., Arenas, M., Serra, N., Bellés, M., Bonet, M., Gascón, M., Vallvé, J.-C., & Linares, V. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217443 · Cited by 31
Finazzi, T., Nguyen, V.-T., Zimmermann, F. B., & Papachristofilou, A. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1364-3 · Cited by 30
Heart dose reduction in breast cancer treatment with simultaneous integrated boost
Jöst, V., Kretschmer, M., Sabatino, M., Würschmidt, F., Dahle, J., Ueberle, F., & Lorenzen, J. (2015) · Strahlentherapie und Onkologie · doi:10.1007/s00066-015-0874-7 · Cited by 29
TUOHINEN, S. S., Skyttä, T., Virtanen, V., Virtanen, M. P. O., Luukkaala, T. H., Kellokumpu‐Lehtinen, P., & Raatikainen, P. M. J. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0837-9 · Cited by 29
Cardio‐Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction
Tromp, J., Steggink, L. C., van Veldhuisen, D. J., Gietema, J. A., & van der Meer, P. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.614 · Cited by 29
“4% per Gray mean dose to the heart, for both women with and without preexisting cardiac risk factors.(36) No dose threshold was observed.”
BackgroundJethwa, K. R., Kahila, M. M. H., Whitaker, T. J., Harmsen, W. S., Corbin, K. S., Park, S. S., Yan, E., Lemaine, V., Boughey, J. C., & Mutter, R. W. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4241-5 · Cited by 29
Kaššák, F., Rossier, C., Picardi, C., & Bernier, J. (2019) · The Breast · doi:10.1016/j.breast.2019.09.008 · Cited by 29
“These cardiac toxicities were frequent and pronounced in mid-twentieth century and were at least partially responsible for the discrepancy between the positive effect of PMRT on LRR and no or even negative effect on OS [41,42].”
BackgroundKanda, M. H., Vieira, R. A. D. C., Lima, J. P. D. S. N., Paiva, C. E., & Araújo, R. L. C. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25820 · Cited by 29
Kennedy, W. R., Thomas, M. A., Stanley, J. A., Luo, J. R., Ochoa, L. L., Clifton, K., Cyr, A. E., Margenthaler, J. A., DeWees, T. A., Price, A., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.02.021 · Cited by 29
Cha, E. S., Zablotska, L. B., Bang, Y. J., & Lee, W. J. (2020) · Occupational and Environmental Medicine · doi:10.1136/oemed-2019-106326 · Cited by 32
Thomsen, M. S., Berg, M., Zimmermann, S. J., Lutz, C. M., Makocki, S., Jensen, I., Hjelstuen, M., Pensold, S., Hasler, M. P., Jensen, M., et al. (2021) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2021.03.009 · Cited by 29
Self-citationPuckett, L. L., Saba, S. G., Henry, S. A., Rosen, S. E., Rooney, E., Filosa, S. L., Gilbo, P., Pappas, K., Laxer, A., Eacobacci, K., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4037 · Cited by 29
Harmonization of breast cancer radiotherapy treatment planning in the Netherlands
Hurkmans, C., Duisters, C., Peters-Verhoeven, M., Boersma, L. J., Verhoeven, K., Bijker, N., Crama, K. F., Nuver, T. T., & van der Sangen, M. (2021) · Technical Innovations & Patient Support in Radiation Oncology · doi:10.1016/j.tipsro.2021.06.004 · Cited by 29
“They used specific DVHs points to report on the heart and lung dose, while we prefer to use the mean heart and lung dose as these are commonly reported on in the literature and correlate with toxicity [14,15].”
Methodvan Velzen, S. G. M., Bruns, S., Wolterink, J. M., Leiner, T., Viergever, M. A., Verkooijen, H. M., & Išgum, I. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.09.009 · Cited by 30
Choi, J. I., Khan, A. J., Powell, S. N., McCormick, B. L., Lozano, A. J., Rosario, G. D., Mamary, J., Liu, H., Fox, P., Gillespie, E. F., et al. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.10.010 · Cited by 29
Socha, J., Rygielska, A., Uziębło‐Życzkowska, B., Chałubińska‐Fendler, J., Jurek, A., Maciorowska, M., Mielniczuk, M., Pawłowski, P., Tyc-Szczepaniak, D., Krzesiński, P., et al. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.12.041 · Cited by 29
Field, M., Thwaites, D., Carolan, M., Delaney, G. P., Lehmann, J., Sykes, J., Vinod, S. K., & Holloway, L. C. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104181 · Cited by 30
Svestad, J. G., Heydari, M., Mikalsen, S. G., Flote, V. G., Nordby, F., & Hellebust, T. P. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.10.017 · Cited by 29
Midlenko, A., Mussina, K., Zhakhina, G., Sakko, Y., Rashidova, G., Saktashev, B., Adilbay, D., Shatkovskaya, O., & Gaipov, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1132742 · Cited by 29
“Different chemotherapy medications such as anthracyclines, fluoropirimidines, taxanes, and HER-2 targeted agents are associated with a high risk of cardiomyopathy, heart failure, as well coronary artery disease (35, 36).”
BackgroundTLR4—A Pertinent Player in Radiation-Induced Heart Disease?
Gawali, B., Sridharan, V., Krager, K. J., Boerma, M., & Pawar, S. A. (2023) · Genes · doi:10.3390/genes14051002 · Cited by 32
“RIHD appears several months to years after RT [6,24,25].”
BackgroundAccelerated hypofractionated breast radiotherapy: FAQs (Frequently Asked Questions) and facts
Montero, A., Sanz, X., Hernánz, R., Cabrera, D., Arenas, M., Bayo, E., Moreno, F., & Algara, M. (2014) · The Breast · doi:10.1016/j.breast.2014.01.011 · Cited by 29
“4% per Gy, with no apparent threshold dose [22].”
BackgroundOlder women’s experience with breast cancer treatment decisions
Schonberg, M. A., Birdwell, R. L., Bychkovsky, B., Hintz, L., Fein-Zachary, V. J., Wertheimer, M. D., & Silliman, R. A. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2921-y · Cited by 29
“However, radiotherapy can cause fatigue, breast pain, and edema and increases the risk of ischemic heart disease [31, 32].”
Unique Aspects of Caring for Young Breast Cancer Patients
Ferzoco, R. M., & Ruddy, K. J. (2015) · Current Oncology Reports · doi:10.1007/s11912-014-0425-x · Cited by 30
Karim, S., Mirza, Z., Chaudhary, A., Abuzenadah, A. M., Gari, M. A., & Al-Qahtani, M. H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020250 · Cited by 30
“Cardiac complication and damage can manifest even years after high-dose radiation treatment [39].”
BackgroundSkyttä, T., Kapanen, M. K., Laaksomaa, M., Peltola, S., Haltamo, M., Boman, E. L., Hyödynmaa, S., & Kellokumpu‐Lehtinen, P. (2016) · Acta Oncologica · doi:10.3109/0284186x.2016.1161823 · Cited by 29
“This excess risk has been shown to be dose-dependent [2] and the heart should be spared from radiation as much as possible.”
BackgroundBecker-Schiebe, M., Stockhammer, M., Hoffmann, W., Wetzel, F., & Franz, H. B. G. (2016) · Strahlentherapie und Onkologie · doi:10.1007/s00066-016-1011-y · Cited by 29
Kaiser, J., Kronberger, C., Moder, A., Kopp, P., Wallner, M., Reitsamer, R., Fischer, T., Fussl, C., Zehentmayr, F., Sedlmayer, F., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.05.028 · Cited by 29
“Darby et al (33) assumed that every 1 Gy mean heart dose increases the risk for a serious cardiac event by 7.”
BackgroundInfluentialKim, D. Y., Youn, J., Park, M., Lee, S., Choi, S.-W., Ryu, K.-H., Kim, L. S., Shim, M.-S., Lee, J. J., & Han, S. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.02.001 · Cited by 32
Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease
Lautenschläger, S., Iancu, G., Flatten, V., Baumann, K., Thiemer, M., Dumke, C., Zink, K., Hauswald, H., Vordermark, D., Mauz‐Körholz, C., et al. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1360-7 · Cited by 30
Killander, F., Wieslander, E., Karlsson, P., Holmberg, E. C., Lundstedt, D., Holmberg, L., Werner, L., Koul, S. M., Haghanegi, M., Kjellén, E., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.04.003 · Cited by 33
Xie, Y., Bourgeois, D. J., Guo, B., & Zhang, R. (2020) · Medical dosimetry · doi:10.1016/j.meddos.2020.05.004 · Cited by 30
Duma, M. N., Molls, M., & Trott, K.-R. (2013) · Strahlentherapie und Onkologie · doi:10.1007/s00066-013-0465-4 · Cited by 30
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy
Busschaert, S.-L., Kimpe, E., Gevaert, T., Ridder, M. D., & Putman, K. D. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.04.009 · Cited by 30
Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity
Jones, S. B., Marchant, T., Saunderson, C. E. D., McWilliam, A., & Banfill, K. (2024) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.13737 · Cited by 28
DCIS Treated with Excision Alone Using the National Comprehensive Cancer Network (NCCN) Guidelines
Wehner, P. B., Lagios, M. D., & Silverstein, M. J. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3176-2 · Cited by 30
Metadata
- Authors
- Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.-B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., & Hall, P.
- Affiliations
- University of Oxford (GB)
- University of Southern Denmark (DK)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Aalborg University Hospital (DK)
- University of South Florida (US)
- Danderyds sjukhus (SE)
- Rigshospitalet (DK)
- Royal Surrey County Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 987-998
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154375587
- Cited by
- 3,974
- References
- 38
- Citations by year
- 2026: 277 · 2025: 290 · 2024: 270 · 2023: 358 · 2022: 359 · 2021: 392 · 2020: 344 · 2019: 285 · 2018: 278 · 2017: 268 · 2016: 285 · 2015: 259 · 2014: 195 · 2013: 107
- FWCI
- 191.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK
- National Institute for Health and Care Research (RRX 108)
- British Heart Foundation (RE/08/004, CRE RE/08/004)
- University of Oxford (RE/08/004)
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- breast cancer radiotherapy, ischemic heart disease, coronary events, myocardial infarction, coronary revascularization, radiation-induced heart disease, left anterior descending artery, radiation dose, cardiovascular risk factors, women
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, Heart, Humans, Mastectomy, Middle Aged, Radiation Injuries, Radiotherapy Dosage, Risk, Risk Factors, Case-Control Studies, Chemotherapy, Adjuvant, Myocardial Ischemia, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.